Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis 2020 to 2024

Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis 2020 to 2024

Cell Based Assays are a mainstay of drug development and scientific research, but growth is now accelerating as new immuno-oncology markets create unprecedented investment in the race to cure cancer. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.


1. Introduction and Market Definition
1.1 What are Cell Based Assays?
1.2 Clinical Trial Failures
1.2.1 Immuno-oncology Plays a Leading Role in Cell Based Assays
1.3 Market Definition
1.3.1 Market Size
1.3.2 Currency
1.3.3 Years
1.4 Methodology
1.4.1 Authors
1.4.2 Sources
1.5 U.S. Medical Market and Pharmceutical Research Spending -
Perspective
1.5.1 U.S. Expenditures for Pharmaceutical Research
2. Cell Based Assays – Guide to Technology
Cell Based Assay & High Content Screening Markets 2020 to 2024 Page | 5
2.1 Cell Cultures
2.1.1 Cell Lines
2.1.2 Primary Cells
2.1.3 Stem Cells
2.1.3.1 iPSC’s – The Special Case
2.2 Cell Assays
2.3 Cell Viability Assays
2.3 Cell Proliferation Assays
2.4 Cytotoxicity Assays
2.5 Cell Senescence Assays
2.6 Apoptosis
2.7 Autophagy
2.8 Necrosis
2.9 Oxidative Stress
2.10 2D vs. 3D
2.11 Signalling Pathways, GPCR
2.12 Immune Regulation & Inhibition
2.13 Reporter Gene Technology
2.14 CBA Design & Development
2.15 Cell Based Assays – The Takeaway
3. Industry Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
Cell Based Assay & High Content Screening Markets 2020 to 2024 Page | 6
3.1.2 Contract Research Organization
3.1.3 Genomic Instrumentation Supplier
3.1.5 Cell Line and Reagent Supplier
3.1.6 Pharmaceutical Company
3.1.7 Audit Body
3.1.8 Certification Body
4. Market Trends
4.1 Factors Driving Growth
4.1.1 Candidate Growth
4.1.2 Immuno-oncology
4.1.3 Genomic Blizzard
4.1.4 Technology Convergence
4.1.5 The Insurance Effect
4.2 Factors Limiting Growth
4.2.1 CBA Development Challenges
4.2.2 Instrument Integration
4.2.3 Protocols
4.3 Technology Development
4.3.1 3D Assays
4.3.2 Automation
4.3.3 Software
4.3.4 Primary Cells
4.3.5 Signalling and Reporter Genes
Cell Based Assay & High Content Screening Markets 2020 to 2024 Page | 7
4.3.6 The Next Five Years
5. Cell Based Assays Recent Developments
5.1 Recent Developments – Importance and How to Use This Section.. 82
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
High-throughput Identifies cancer drug candidates
Velabs Therapeutics partners with Alytas Therapeutics to develop a
novel immune-based therapy for obesity
InSphero platform selected to test Cyclerion's sGC stimulator
technology
OcellO to provide in vitro research services to Merus
Charles River Laboratories to acquire Citoxlab
Reaction Biology Corporation Purchases ProQinase GmbH
Cisbio extends its assay portfolio for immuno-oncology drug discovery 90
STEMCELL Technologies Launches Next-Generation Culture System
Abcam Acquires Calico Biolabs
Evotec announces achievement in Celgene alliance utilizing IPSC
screening
Fujifilm Cellular Dynamics Inc. launches iCELL Microglia
Cisbio and Excellerate Bioscience partner
Agilent Acquires Luxcel Biosciences
Horizon Discovery extends CRISPR Screening Service to primary human T
cells
BioIVT Acquires Biological Specialty Corporation
Cell Based Assay & High Content Screening Markets 2020 to 2024 Page | 8
Miltenyi Biotec acquires microscopy specialist LaVision BioTec
BioIVT acquires Clinical Trials Laboratory Services
ACEA Biosciences to be Acquired by Agilent Technologies
Olympus announces new 3D Cell Analysis technology
Beckman Coulter Launches Flow Cytometry Software
Agilent Technologies Inc. and BioTek Instruments, Inc to Create
Integrated Metabolic Analysis and Imaging Platform
Molecular Devices launches new features for ImageXpress Pico
Automated Cell Imaging System
Ncardia Launches Custom CRISPR Gene-editing in iPSC-derived Cell
Lines with Horizon Discovery as Partner
MilliporeSigma to sell Flow Cytometry Unit
Charles River Laboratories purchases Nanion Syncropatch 384PE
Reaction Biology and Promega announce new NanoBRET Technology
Nanion Technologies and Ncardia to enhance Options for Cardiac
Researchers
Citoxlab signs deal with Experimental Pharmacology and Oncology
Berlin-Buch GmbH (EPO)
Battery Ventures Acquires TTP Labtech Limited
BD Launches Cell Sorter to Enable Sorting of Rare Cell Types
Enzo Life Sciences Introduces Validated Antibodies for IHC
Sartorius launches new high throughput bioreactor system
6. Profiles of Key Cell Based Assay Companies
Abcam
Cell Based Assay & High Content Screening Markets 2020 to 2024 Page | 9
Agilent
Beckman Coulter, Inc.
Becton Dickinson
BioIVT
Bio-Rad Laboratories, Inc.
BioTek Instruments
BioVision, Inc.
Cell Biolabs, Inc
Cell Signaling Technology, Inc.
Charles River Laboratories, Inc.
Cisbio Bioassays
Corning, Inc
Cytovale
Enzo Life Sciences, Inc.
Eurofins DiscoverX Corporation
Evotec AG
Excellerate Bioscience
Fujifilm Cellular Dynamics International
GE Healthcare Life Sciences
Hemogenix
Horizon Discovery Group plc
Invivogen
Leica Biosystems
Cell Based Assay & High Content Screening Markets 2020 to 2024 Page | 10
Lonza Group Ltd.
Merck KgaA
Miltenyi Biotec
Molecular Devices
Nanion
Ncardia
New England Biolabs, Inc
Olympus
Origene Technologies
PerkinElmer, Inc
Promega Corporation
Qiagen NV
Reaction Biology
Roche Group
Sartorius
Sony Biotechnology
Stemcells Technologies Canada Inc.
Thermo Fisher Scientific, Inc.
TTP Labtech
Vitro Biopharma
7. Global Market Size
7.1 Cell Based Assay Global Market Size by Region with Charts
7.2 Cell Based Assays Global Market Size by Type with Charts
Cell Based Assay & High Content Screening Markets 2020 to 2024 Page | 11
8. Global Market by User Type
8.1 Pharmaceutical Market
8.1.1 Pharmaceutical Market by Region with Chart
8.2 Basic Research Market
8.2.1 Basic Research Market by Region with Chart
8.3 Industrial/Cosmetic Market
8.3.1 Industrial/Cosmetic Market by Region with Chart
9. Cell Based Assay by Product Class
9.1 Instrument Market
9.1.1 Instrument Market by Region with Chart
9.2 Reagent Market
9.2.1 Reagent Market by Region with Chart
9.3 Services Market
9.3.1 Services Market by Region with Chart
9.4 Software Market
9.4.1 Software Market by Region with Chart
10. Appendices
10.1 FDA Cancer Drug Approvals by Year
10.2 Clinical Trials Started 2010 to 2016
10.3 Share of Pharma R&D by Country
Cell Based Assay & High Content Screening Markets 2020 to 2024 Page | 12
Table of Tables
Table 1 The Large Variety of Cell Lines
Table 2 Some Common Viability Assays
Table 3 Oxidative Stress Related Diseases
Table 4 Important Signalling Pathways
Table 5 Market Players by Type
Table 6 Five Factors Driving Growth
Table 7 Three Factors Limiting Growth
Table 8 Cell Based Assays Global Market by Region
Table 9 Cell Based Assays Global Market by User Type
Table 10 Pharmaceutical Market by Region
Table 11 Basic Research Market by Region
Table 12 Industrial/Cosmetic Market by Region
Table 13 Instrument Market by Region
Table 14 Reagent Market by Region
Table 15 Services Market by Region
TABLE 16 SOFTWARE MARKET BY REGION
Table of Figures
Figure 1 Reasons for clinical Failure by Phase
Cell Based Assay & High Content Screening Markets 2020 to 2024 Page | 13
Figure 2 Immunotherapy Clinical Trial Growth
Figure 3 Pharmaceutical Research Expenditures 2001 to 2017 ($Billion)
Figure 4 Oxidative Stress and Free Radical Toxicity
Figure 5 FDA Cancer Drug Approvals
Figure 6 Growth rates of Cell Based Assays by Product Class
Figure 7 Market Size by Region
Figure 8 Global Market by Region
Figure 9 Chart of Global Market by User Type
Figure 10 Growth Rates of Industry Segments
Figure 11 Cell Based Assay Share Change by User Type
Figure 12 Chart – Pharmaceutical Market by Region
Figure 13 Chart – Basic Research Market by Region
Figure 14 Chart – Industrial/Cosmetic Market by Region
Figure 15 Chart – Instrument Market by Region
Figure 16 Chart – Reagent Market by Region
Figure 17 Chart –Services Market by Region
FIGURE 18 CHART –SOFTWARE MARKET BY REGION
Figure 19 FDA Cancer Drug Approvals by Year
Figure 20 Clinical Trials for Immunotherapy by Year
Figure 21 Share of Pharma R&D by Country

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook